Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.

von Neu, H C, Meropol, N J, Fu, K P
Veröffentlicht 1981

Patient–physician discordance in goals of care for patients with advanced cancer

von Douglas, S.L., Daly, B.J., Meropol, N.J., Lipson, A.R.
Veröffentlicht in Curr Oncol (2019)

Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods.

von Mandelblatt, J S, Bierman, A S, Gold, K, Zhang, Y, Ng, J H, Maserejan, N, Hwang, Y T, Meropol, N J, Hadley, J, Silliman, R A
Veröffentlicht 2001

Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer

von Dotan, E, Meropol, N J, Zhu, F, Zambito, F, Bove, B, Cai, K Q, Godwin, A K, Golemis, E A, Astsaturov, I, Cohen, S J
Veröffentlicht 2012

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

von Cohen, S J, Konski, A A, Putnam, S, Ball, D S, Meyer, J E, Yu, J Q, Astsaturov, I, Marlow, C, Dickens, A, Cade, D N, Meropol, N J
Veröffentlicht 2014

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

von Zurita, A J, Khajavi, M, Wu, H-K, Tye, L, Huang, X, Kulke, M H, Lenz, H-J, Meropol, N J, Carley, W, DePrimo, S E, Lin, E, Wang, X, Harmon, C S, Heymach, J V
Veröffentlicht in Br J Cancer (2015)

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers

von MANNE, S., KASHY, D., ALBRECHT, T., WONG, Y.-N., FLAMM, A. LEDERMAN, BENSON, A. B., MILLER, S.M., FLEISHER, LINDA, BUZAGLO, J., ROACH, N., KATZ, M., ROSS, E., COLLINS, M., POOLE, D., RAIVITCH, S., MILLER, D.M., KINZY, T.G., LIU, T., MEROPOL, N.J.
Veröffentlicht in Eur J Cancer Care (Engl) (2014)